Thyroid eye disease. More treatment options.
نویسندگان
چکیده
منابع مشابه
Thyroid eye disease.
Most patients receive conservative treatment — lubrication of the eye to reduce symptoms related to disturbance of the tear film. About 5% of patients will need more aggressive therapy (e.g., systemic corticosteroids, orbital radiation, surgical removal of orbital walls) to prevent vision loss caused by either compression of the optic nerve by enlarging extraocular muscles or corneal ulceration...
متن کاملThyroid Eye Disease
Treatment ........................................................... 16 Introduction to treatment ................................ 16 Management of systemic hyperthyroidism...... 17 Overview of treatment options ....................... 20 o Corticosteroids .......................................... 20 o Orbital radiotherapy .................................. 20 o Selenium ..................
متن کاملThyroid Eye Disease
Management is challenging and requires a team approach. Medical management is only available in the active, early phase. When the disease becomes inactive (no acute inflammation), surgery is the only option. TED is sight-threatening in up to 5% of patients, although most cases are mild and self-limiting. [1]See also separate articles Thyroid Function Tests, Hyperthyroidism, Hyperthyroidism in P...
متن کاملMethotrexate for the Treatment of Thyroid Eye Disease
Background/Aim. To evaluate the efficacy of methotrexate for the treatment of thyroid eye disease (TED). Methods. 36 consecutive patients with active TED, previously treated with corticosteroids but stopped due to the occurrence of side effects, were commenced on methotrexate therapy. Two different weekly doses were administered depending on the weight of the patient (7.5 mg or 10 mg). Clinical...
متن کاملRituximab for thyroid eye disease.
PURPOSE To assess the efficacy and safety of rituximab-mediated B-lymphocyte depletion as treatment for thyroid eye disease (TED). METHODS Prospective, open-label, interventional clinical trial evaluating 12 patients with TED and Clinical Activity Scores (CAS) (VISA [vision, inflammation, strabismus and appearance/exposure] classification) of 4 or greater followed for 1 year after rituximab (...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1993
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.306.6886.1195